Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model.
Li M, Jancovski N, Jafar-Nejad P, Burbano LE, Rollo B, Richards K, Drew L, Sedo A, Heighway J, Pachernegg S, Soriano A, Jia L, Blackburn T, Roberts B, Nemiroff A, Dalby K, Maljevic S, Reid CA, Rigo F, Petrou S.
Li M, et al. Among authors: pachernegg s.
J Clin Invest. 2021 Dec 1;131(23):e152079. doi: 10.1172/JCI152079.
J Clin Invest. 2021.
PMID: 34850743
Free PMC article.